Effect of heme oxygenase-1 on ochratoxin A-induced nephrotoxicity in mice. 2017

Agnieszka Loboda, and Anna Stachurska, and Paulina Podkalicka, and Mateusz Sobczak, and Olga Mucha, and Agnieszka Witalisz-Siepracka, and Alicja Jozkowicz, and Jozef Dulak
Department of Medical Biotechnology, Faculty of Biochemistry, Biophysics and Biotechnology, Jagiellonian University, Krakow, Poland. Electronic address: agnieszka.loboda@uj.edu.pl.

Heme oxygenase-1 (HO-1), a heme-degrading enzyme, is suggested to play an important role in kidney pathophysiology, mostly due to its anti-fibrotic, anti-apoptotic and anti-oxidant properties. One of the mycotoxin, ochratoxin A (OTA) was previously shown to affect HO-1 expression, however, the mechanisms of OTA-induced nephrotoxicity during HO-1 deficiency are unknown. We have shown that OTA regulates the number of pro-fibrotic, pro-inflammatory, anti-oxidative and pro-apoptotic factors in HO-1 dependent manner, as the lack of HO-1 accelerates whereas the induction of HO-1 expression by cobalt protoporphyrin (CoPP) attenuates nephrotoxic effect of OTA. The down-regulation of the nuclear factor-erythroid-2- related factor 2 (Nrf2) transcription factor by OTA, observed in HO-1 knock-out animals, might be another mechanism of OTA toxicity. Moreover, HO-1 level and OTA treatment influences the expression of microRNAs. Namely, p53-regulated miR-34a and pro-fibrotic miR-21 were already increased in HO-1-/- kidneys and were further induced by OTA administration, whereas anti-fibrotic miR-29c was down-regulated by this mycotoxin. Our study indicates that complex mechanisms of OTA nephrotoxicity may be partially overcome by HO-1 induction.

UI MeSH Term Description Entries
D007668 Kidney Body organ that filters blood for the secretion of URINE and that regulates ion concentrations. Kidneys
D008297 Male Males
D008565 Membrane Proteins Proteins which are found in membranes including cellular and intracellular membranes. They consist of two types, peripheral and integral proteins. They include most membrane-associated enzymes, antigenic proteins, transport proteins, and drug, hormone, and lectin receptors. Cell Membrane Protein,Cell Membrane Proteins,Cell Surface Protein,Cell Surface Proteins,Integral Membrane Proteins,Membrane-Associated Protein,Surface Protein,Surface Proteins,Integral Membrane Protein,Membrane Protein,Membrane-Associated Proteins,Membrane Associated Protein,Membrane Associated Proteins,Membrane Protein, Cell,Membrane Protein, Integral,Membrane Proteins, Integral,Protein, Cell Membrane,Protein, Cell Surface,Protein, Integral Membrane,Protein, Membrane,Protein, Membrane-Associated,Protein, Surface,Proteins, Cell Membrane,Proteins, Cell Surface,Proteins, Integral Membrane,Proteins, Membrane,Proteins, Membrane-Associated,Proteins, Surface,Surface Protein, Cell
D008810 Mice, Inbred C57BL One of the first INBRED MOUSE STRAINS to be sequenced. This strain is commonly used as genetic background for transgenic mouse models. Refractory to many tumors, this strain is also preferred model for studying role of genetic variations in development of diseases. Mice, C57BL,Mouse, C57BL,Mouse, Inbred C57BL,C57BL Mice,C57BL Mice, Inbred,C57BL Mouse,C57BL Mouse, Inbred,Inbred C57BL Mice,Inbred C57BL Mouse
D009793 Ochratoxins Isocoumarins found in ASPERGILLUS OCHRACEUS and other FUNGI. Ochratoxin contaminated FOOD has been responsible for cases of FOODBORNE DISEASES. Ochratoxin
D011524 Protoporphyrins Porphyrins with four methyl, two vinyl, and two propionic acid side chains attached to the pyrrole rings. Protoporphyrin IX occurs in hemoglobin, myoglobin, and most of the cytochromes.
D005260 Female Females
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000975 Antioxidants Naturally occurring or synthetic substances that inhibit or retard oxidation reactions. They counteract the damaging effects of oxidation in animal tissues. Anti-Oxidant,Antioxidant,Antioxidant Activity,Endogenous Antioxidant,Endogenous Antioxidants,Anti-Oxidant Effect,Anti-Oxidant Effects,Anti-Oxidants,Antioxidant Effect,Antioxidant Effects,Activity, Antioxidant,Anti Oxidant,Anti Oxidant Effect,Anti Oxidant Effects,Anti Oxidants,Antioxidant, Endogenous,Antioxidants, Endogenous
D012333 RNA, Messenger RNA sequences that serve as templates for protein synthesis. Bacterial mRNAs are generally primary transcripts in that they do not require post-transcriptional processing. Eukaryotic mRNA is synthesized in the nucleus and must be exported to the cytoplasm for translation. Most eukaryotic mRNAs have a sequence of polyadenylic acid at the 3' end, referred to as the poly(A) tail. The function of this tail is not known for certain, but it may play a role in the export of mature mRNA from the nucleus as well as in helping stabilize some mRNA molecules by retarding their degradation in the cytoplasm. Messenger RNA,Messenger RNA, Polyadenylated,Poly(A) Tail,Poly(A)+ RNA,Poly(A)+ mRNA,RNA, Messenger, Polyadenylated,RNA, Polyadenylated,mRNA,mRNA, Non-Polyadenylated,mRNA, Polyadenylated,Non-Polyadenylated mRNA,Poly(A) RNA,Polyadenylated mRNA,Non Polyadenylated mRNA,Polyadenylated Messenger RNA,Polyadenylated RNA,RNA, Polyadenylated Messenger,mRNA, Non Polyadenylated

Related Publications

Agnieszka Loboda, and Anna Stachurska, and Paulina Podkalicka, and Mateusz Sobczak, and Olga Mucha, and Agnieszka Witalisz-Siepracka, and Alicja Jozkowicz, and Jozef Dulak
November 2018, Renal failure,
Agnieszka Loboda, and Anna Stachurska, and Paulina Podkalicka, and Mateusz Sobczak, and Olga Mucha, and Agnieszka Witalisz-Siepracka, and Alicja Jozkowicz, and Jozef Dulak
October 2012, Antimicrobial agents and chemotherapy,
Agnieszka Loboda, and Anna Stachurska, and Paulina Podkalicka, and Mateusz Sobczak, and Olga Mucha, and Agnieszka Witalisz-Siepracka, and Alicja Jozkowicz, and Jozef Dulak
April 2006, American journal of surgery,
Agnieszka Loboda, and Anna Stachurska, and Paulina Podkalicka, and Mateusz Sobczak, and Olga Mucha, and Agnieszka Witalisz-Siepracka, and Alicja Jozkowicz, and Jozef Dulak
January 2001, Kidney international,
Agnieszka Loboda, and Anna Stachurska, and Paulina Podkalicka, and Mateusz Sobczak, and Olga Mucha, and Agnieszka Witalisz-Siepracka, and Alicja Jozkowicz, and Jozef Dulak
November 2007, Journal of gastroenterology and hepatology,
Agnieszka Loboda, and Anna Stachurska, and Paulina Podkalicka, and Mateusz Sobczak, and Olga Mucha, and Agnieszka Witalisz-Siepracka, and Alicja Jozkowicz, and Jozef Dulak
January 1995, Toxicology,
Agnieszka Loboda, and Anna Stachurska, and Paulina Podkalicka, and Mateusz Sobczak, and Olga Mucha, and Agnieszka Witalisz-Siepracka, and Alicja Jozkowicz, and Jozef Dulak
September 2010, European journal of pharmacology,
Agnieszka Loboda, and Anna Stachurska, and Paulina Podkalicka, and Mateusz Sobczak, and Olga Mucha, and Agnieszka Witalisz-Siepracka, and Alicja Jozkowicz, and Jozef Dulak
January 2015, International journal of medical sciences,
Agnieszka Loboda, and Anna Stachurska, and Paulina Podkalicka, and Mateusz Sobczak, and Olga Mucha, and Agnieszka Witalisz-Siepracka, and Alicja Jozkowicz, and Jozef Dulak
May 2015, Diabetes,
Agnieszka Loboda, and Anna Stachurska, and Paulina Podkalicka, and Mateusz Sobczak, and Olga Mucha, and Agnieszka Witalisz-Siepracka, and Alicja Jozkowicz, and Jozef Dulak
October 2016, Oncotarget,
Copied contents to your clipboard!